About MolecularMatch
MolecularMatch is a company based in Houston (United States) founded in 2013. MolecularMatch has raised $3.69 million across 2 funding rounds from investors including Squarespace and Houston Angel Network. The company has 6 employees as of December 31, 2022. MolecularMatch offers products and services including MMPower, MMLab, MMPortal, and MMTherapeutics. MolecularMatch operates in a competitive market with competitors including Evidation, Helix, Benchling, Prenetics and Genuity Science, among others.
- Headquarter Houston, United States
- Employees 6 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molecularmatch Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.69 M (USD)
in 2 rounds
-
Latest Funding Round
$593 K (USD), Series A
Aug 05, 2014
-
Investors
Squarespace
& 1 more
-
Employee Count
6
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MolecularMatch
MolecularMatch offers a comprehensive portfolio of products and services, including MMPower, MMLab, MMPortal, and MMTherapeutics.
Platform for clinical decision support in oncology.
Tool for processing and analyzing genomic data.
Portal for molecular knowledgebase and insights.
Solution for targeted molecular treatment options.
Funding Insights of MolecularMatch
MolecularMatch has successfully raised a total of $3.69M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $593 thousand completed in August 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MolecularMatch
MolecularMatch has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Squarespace and Houston Angel Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Houston Angel Network is focused on supporting startups with funding.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for MolecularMatch
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MolecularMatch
Investment portfolio details for MolecularMatch
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MolecularMatch
Detailed financials for MolecularMatch
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecularmatch Comparisons
Peer comparison for MolecularMatch
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MolecularMatch
MolecularMatch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evidation, Helix, Benchling, Prenetics and Genuity Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Real-world health data is provided for research and decisions.
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
Detailed competitors of MolecularMatch
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecularmatch
Complete news archive for MolecularMatch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MolecularMatch
MolecularMatch was founded in 2013 and raised its 1st funding round 1 year after it was founded.
MolecularMatch is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
MolecularMatch is a funded company, having raised a total of $3.69M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at MolecularMatch is 6.
MolecularMatch was founded in 2013 in Houston, United States, within the health technology sector. A SaaS-based platform is provided to match patients with personalized medicines using genetic disease signatures. Enrollment in global clinical trials is facilitated through a free database. Pharmacogenomics software tailored for pathology labs is also supplied to support targeted drug development and trial access.
MolecularMatch offers MMPower, MMLab, MMPortal, and MMTherapeutics.
MolecularMatch has 2 investors. Key investors include Squarespace, and Houston Angel Network.